日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Awareness of Risk Minimization Measures for Valproate and Pregnancy Prevention Program Compliance Among Pharmacists: A Cross-Sectional Survey in Romania

罗马尼亚药剂师对丙戊酸风险最小化措施的认知及妊娠预防计划依从性：一项横断面调查

期刊:Pharmaceuticals
影响因子:4.8
doi:10.3390/ph18121861
Huruba, Madalina; Leucuta, Daniel; Farcas, Andreea; Mogosan, Cristina
神经科学
发表日期：2025
文献求助 收藏

Prevalence and Risk Factors Associated with Potentially Inappropriate Prescribing According to STOPP-2 Criteria among Discharged Older Patients-An Observational Retrospective Study

根据STOPP-2标准，出院老年患者潜在不合理处方的患病率及相关风险因素——一项观察性回顾性研究

期刊:Pharmaceuticals
影响因子:4.8
doi:10.3390/ph16060852
Sipos, Mariana; Farcas, Andreea; Leucuta, Daniel Corneliu; Bulik, Noémi-Beátrix; Huruba, Madalina; Dumitrascu, Dan; Mogosan, Cristina
发表日期：2023
文献求助 收藏

Short duration overnight cattle kraaling in natural rangelands: Does time after kraal use affect their utilization by wildlife and above ground grass parameters?

在天然牧场中短期过夜圈养牛群：圈养后的时间是否会影响野生动物对牛群的利用以及地上牧草的参数？

期刊:PLoS One
影响因子:2.6
doi:10.1371/journal.pone.0248795
Huruba, Rangarirai; Nemera, Servious; Ngute, Faith; Sahomba, Meshack; Mundy, Peter J; Sebata, Allan; MacFadyen, Duncan N
发表日期：2022
文献求助 收藏

A VigiBase descriptive study of fluoroquinolone induced disabling and potentially permanent musculoskeletal and connective tissue disorders

VigiBase对氟喹诺酮类药物诱发的致残性且可能永久性的肌肉骨骼和结缔组织疾病的描述性研究

期刊:Scientific Reports
影响因子:3.9
doi:10.1038/s41598-021-93763-y
Huruba, Madalina; Farcas, Andreea; Leucuta, Daniel Corneliu; Bucsa, Camelia; Sipos, Mariana; Mogosan, Cristina
发表日期：2021
文献求助 收藏

Survery of healthcare professionals to assess the awareness, knowledge and self-reported behavior regarding recent fluoroquinolones safety issues

对医疗保健专业人员进行调查，以评估他们对近期氟喹诺酮类药物安全问题的认识、知识和自我报告的行为。

期刊:Medicine and Pharmacy Reports
影响因子:
doi:10.15386/mpr-1979
Huruba, Madalina; Farcas, Andreea; Leucuta, Daniel Corneliu; Sipos, Mariana; Mogosan, Cristina
发表日期：2021
文献求助 收藏

Study design, process and outcome indicators of post-authorization studies aimed at evaluating the effectiveness of risk minimization measures in the EU PAS Register

本文探讨了旨在评估欧盟PAS注册库中风险最小化措施有效性的上市后研究的研究设计、过程和结果指标。

期刊:British Journal of Clinical Pharmacology
影响因子:3
doi:10.1111/bcp.13824
Farcas, Andreea; Huruba, Madalina; Mogosan, Cristina
中风
心血管
发表日期：2019
文献求助 收藏